UCLA, Medical Center Division of Hematology/Oncology (119) — Los Angeles, California

UCLA, Medical Center Division of Hematology/Oncology (119) is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA, Medical Center Division of Hematology/Oncology (119) has participated in 1 clinical trials.

Therapeutic areas: AML With Monocytic Differentiation, CMML.

Sponsors: Immune-Onc Therapeutics.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA, Medical Center Division of Hematology/Oncology (119)?

UCLA, Medical Center Division of Hematology/Oncology (119) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA, Medical Center Division of Hematology/Oncology (119) conducted?

UCLA, Medical Center Division of Hematology/Oncology (119) has 1 clinical trials on record. Their work covers AML With Monocytic Differentiation, CMML.

Is UCLA, Medical Center Division of Hematology/Oncology (119) accredited by Crixeo Health?

UCLA, Medical Center Division of Hematology/Oncology (119) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA, Medical Center Division of Hematology/Oncology (119)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.